FP01.04 BTCRC LUN19-396: Adjuvant Chemotherapy Plus Atezolizumab in Stage IB-IIIA Resected NSCLC and Clearance of ctDNA
Autor: | Yan, M., Durm, G., Jalal, S., Einhorn, L., Kesler, K., Rieger, K., Birdas, T., Ceppa, D., Hanna, N. |
---|---|
Zdroj: | In Journal of Thoracic Oncology March 2021 16(3) Supplement:S187-S188 |
Databáze: | ScienceDirect |
Externí odkaz: |